-
Thematic Analysis
Wealth Management Sector Scorecard – Thematic Intelligence
Wealth Management Sector Scorecard Thematic Intelligence Report Overview The wealth management sector must continuously invest in key themes to capture more market share. Digital investment platforms with the infusion of emerging technologies, such as artificial intelligence (AI) and machine learning, can offer customers efficient personalized services. This will not only help players retain customers but also gain a competitive advantage. Environmental, social, and governance (ESG) services remain a key theme in the wealth space, accelerated due to the pandemic. Wealth...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRPH-222 in Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TRPH-222 in Lymphoma Drug Details: TRPH-222 is under development for the treatment of relapsed and...
-
Company Insights
Pictet Group – Competitor Profile
Pictet Group Competitor Profile Overview Headquartered in Geneva, Switzerland, Pictet Group is a corporate partnership offering wealth management and investment services in Europe, Asia, the Americas, and the Middle East. The group has 30 offices in 19 countries around the world. It has four divisions: Asset Management, Wealth Management, Alternative Advisors, and Asset Services. The Pictet Group competitor profile report comprehensively analyzes Pictet Group's private banking operations. It offers insights into the company’s strategy and financial performance, including key data...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRPH-222 in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRPH-222 in Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TRPH-222 in Lymphoma Drug Details:TRPH-222 is under development for the treatment of relapsed and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRPH-222 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRPH-222 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TRPH-222 in Marginal Zone B-cell Lymphoma Drug Details:TRPH-222 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRPH-222 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRPH-222 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TRPH-222 in Diffuse Large B-Cell Lymphoma Drug Details:TRPH-222 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TRPH-222 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRPH-222 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TRPH-222 in Mantle Cell Lymphoma Drug Details:TRPH-222 is under development for the...
-
Analyst Opinions
Thailand Wealth Management – High Net Worth (HNW) Investors
Thailand Wealth Management Report Overview Thai HNW investors skew heavily towards males, but female entrepreneurs represent a lucrative target segment. This gender imbalance is higher than in the overall Asia-Pacific region. Wealth managers should examine whether their current engagement strategies fuel this imbalance and alienate female clients. The Thailand wealth management market report analyzes the investment preferences, service requirements, and portfolio allocation of Thailand's HNW investors. The report is based on GlobalData’s proprietary Global Wealth Managers Survey. Key Investment Preferences...
-
Company Profile
Pictet & Cie Group SCA – Company Profile
Pictet & Cie Group SCA (PCG) offers wealth management, asset management, and asset services. Wealth Management offers customized discretionary and advisory investment solutions across all asset classes and execution-only and family-office services. Asset management includes investment management services through mutual funds and segregated accounts. It manages fixed-income, equity, alternatives, and multi-asset strategies. Asset services consist of custody services, fund solutions, and trading services. Alternative investments comprise private equity, hedge funds, and real estate. Alternative investments offer hedge fund and private...
Add to Basket